HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congresswoman, Pageant Winner Back Petition For Final Sunscreen Regs

This article was originally published in The Tan Sheet

Executive Summary

A consumer advocacy group gets support from a member of Congress and a beauty pageant winner as well as industry stakeholders for its citizen petition to light a fire under FDA about making state-of-the-art, broad-spectrum sunscreens available in the U.S

You may also be interested in...



Lowey reintroduces sunscreen monograph bill

Rep. Nita Lowey, D-N.Y., reintroduces the Skin Cancer Prevention, Education, and Consumer Right-To-Know Act April 23. The bill, H.R. 2088, would give FDA 180 days to finalize its long-awaited monograph for broad-spectrum sunscreen ingredients that protect consumers from both UVA and UVB rays. The legislation, similar to a bill Lowey introduced in the previous Congress, would also require the Department of Health and Human Services to initiate a nationwide education campaign on the importance of sunscreen application (1"The Tan Sheet" Dec. 15, 2008, p. 12). The legislation was referred to the House Energy and Commerce Committee

FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data

FDA's recent decision that the breakthrough UVA filtering ingredient ecamsule is eligible for inclusion in the OTC sunscreen drug monograph pending a safety and efficacy evaluation could level the playing field among competing manufacturers in the U.S. and offer innovators more flexibility

Ciba Still Seeks Addition Of UVA Filters To FDA Sunscreen Monograph

As FDA continues work toward finalizing its sunscreen monograph, Ciba Specialty Chemicals awaits a decision on whether two UVA filter ingredients it manufactures will be included in the final rule

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS137080

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel